ESR1 and breast carcinoma: Among breast cancer molecular subtypes, triple-negative breast cancer (TNBC), defined by the lack of estrogen (ER), progesterone (PR) and human epidermal growth factor receptor 2 (HER-2) expression, is the most lethal subtype of breast cancer with a 5-year mortality of about 40% [7–9].